Some evidence has cropped up indicating that GlaxoSmithKline's infant vaccine Rotarix may boost the risk of a rare but potentially fatal bowel problem. It's intussusception--a condition in which the ...
May 17, 2010 — Rotarix (GlaxoSmithKline) and RotaTeq (Merck) vaccination may be safe and effective at preventing rotavirus disease in childhood, according to the results of a review reported online ...
The FDA is recommending that healthcare practitioners temporarily suspend use of GlaxoSmithKline's Rotarix vaccine for rotavirus immunization in the U.S. while the agency learns more about components ...
(CNN)-- Federal health authorities recommended Monday that doctors suspend using Rotarix, one of two vaccines licensed in the United States against rotavirus, saying the vaccine is contaminated with ...
Bear Stearns maintained a "peer perform" rating on Merck after the company said it received regulatory approval for RotaTeq, a treatment for an infantile digestive disease. Shares of Merck rose late ...
March 22, 2010 — The US Food and Drug Administration (FDA) announced today viral contamination of GlaxoSmithKline's Rotarix vaccine. The agency is recommending that doctors stop using the vaccine ...
This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. The Food and Drug Administration on Monday warned doctors and parents ...
Rotarix on par with Rotateq for rotavirus gastroenteritis The monovalent rotavirus vaccine is more than 90% effective at preventing rotavirus, putting the vaccine's efficacy on par with the ...
WASHINGTON — Federal drug regulators on Monday asked the nation’s pediatricians to stop giving children a diarrhea vaccine until federal scientists can figure out why the product contains apparently ...
GlaxoSmithKline says that it is launching Rotarix – a new vaccine against rotavirus, a condition that can lead to severe diarrhoea, dehydration and death if left untreated – in its first market of ...
Two doses of the monovalent rotavirus vaccine (RV1, Rotarix, GlaxoSmithKline) is more than 90% effective at preventing severe rotavirus-associated gastroenteritis, putting the vaccine’s efficacy on ...